Charles River Laboratories International

company

About

Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.

  • 5001 - 10000

Details

Last Funding Type
Grant
Last Funding Money Raised
$34M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 1947
Number Of Employee
5001 - 10000
Operating Status
Active

Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$34M
Charles River Laboratories International has raised a total of $34M in funding over 2 rounds. Their latest funding was raised on Sep 29, 2011 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 29, 2011 Grant $34M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Charles River Laboratories International is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant